Hyung Koo Kang

Hyung Koo Kang

Auto-generated profile, based on publicly available information

Hyung Koo Kang

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Gyeonggi, Republic of Korea

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2015 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
HKHyung Koo Kang
Hyung Koo Kang
HPHye Yun Park
Hye Yun Park
DKDohun Kim
Dohun Kim
Byeong-Ho JeongByeong-Ho Jeong
Byeong-Ho Jeong
Kyeongman JeonKyeongman Jeon
Kyeongman Jeon
WKWon-Jung Koh
Won-Jung Koh
Outcomes of antibiotic treatment for lung disease caused by nontuberculous mycobacteria (NTM) are unsatisfactory. The role of adjunctive surgery in the treatment of NTM lung disease is still unclear. We conducted a retrospective review of 70 patients who underwent pulmonary resection for NTM lung disease from March 2007 to February 2013. All patients received recommended antibiotic treatment before and after the surgery. A total of 70 patients underwent 74 operations. The median age of the patients was 50 years. Of the 70 patients, 45 (64%) had Mycobacterium avium complex infection (24 M. intracellulare and 21 M. avium) and 23 (33%) had M. abscessus complex infection (15 M. abscessus and 8 M. massiliense). Thirty-eight (54%) patients had the nodular bronchiectatic form and 28 (40%) had the fibrocavitary form of NTM lung disease. The indications for surgery were a poor response to drug therapy (n=52), remnant cavitary lesions and severe bronchiectasis (n=14), and hemoptysis (n=4). Preoperative sputum acid-fast bacilli staining results were positive in 44 (63%) patients, and sputum culture was positive in 54 (76%). The surgery included lobectomy or lobectomy plus segmentectomy (n=50, 68%), segmentectomy (n=11, 15%), pneumonectomy or completion pneumonectomy (n=8, 11%), bilobectomy or bilobectomy plus segmentectomy (n=4, 5%), and wedge resection (n=1, 1%). Postoperative complications occurred in 15 (21%) patients, including one postoperative death and bronchopleural fistula in 5 patients with the fibrocavitary form of the disease. A negative sputum culture was achieved and maintained in 57 (81%) patients. Although adjuvant pulmonary resection is associated with a relatively high complication rate, this procedure may provide a high level of treatment success for selected patients with NTM lung disease, such as those with a poor response to antibiotic treatment alone.

1 August 2017 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
MJMoa Jeong
Moa Jeong
HKHyung Koo Kang
Hyung Koo Kang
PSPamela Song
Pamela Song
HPHye Kyeong Park
Hye Kyeong Park
HJHoon Jung
Hoon Jung
HKHyeon-Kyoung Koo
Hyeon-Kyoung Koo
Purpose: Hand grip strength (HGS) is a simple way of predicting the risk of cardiovascular disease and all-cause mortality in the general population. However, the practical significance of grip strength in patients with COPD is uncertain. The aim of this study was to compare HGS between subjects with and without COPD and to evaluate its clinical relevance in patients with COPD by using a national survey. Methods: Data were collected from the Korean National Health and Nutrition Examination Survey. The study included 421 adults with COPD and 2,542 controls who completed questionnaires, spirometry, and a HGS test. HGS was compared between subjects with and without COPD, and the association between grip strength, lung function, and quality of life (QoL) was evaluated. Results: The mean HGS was 33.3±9.1 kg in the COPD group and 29.9±9.5 kg in the non-COPD group; adjusted HGS was 30.9±0.33 kg and 30.9±0.11 kg, respectively (P=0.99). HGS was not related to forced vital capacity (β=0.04, P=0.70) or forced expiratory volume in 1 second (β=0.11, P=0.24) in multivariable analysis. HGS was independently associated with the EQ-5D index, but the relationship was stronger in the COPD group (β=0.30, P<0.001) than in the non-COPD group (β=0.21, P<0.001). The results were similar for each component of the EQ-5D, including mobility (β=-0.25, P<0.001), daily activity (β=-0.19, P=0.01), pain/discomfort (β=-0.32, P<0.001), and anxiety/depression (β=-0.16, P=0.01). Conclusion: HGS was not different between subjects with and without COPD, but was associated with QoL – including mobility, daily activity, pain/discomfort, and anxiety/depression – in patients with COPD. The HGS test could be used as a marker of QoL in patients with COPD and could assist risk stratification in clinical practice.

1 January 2017 in Tuberculosis and Respiratory Diseases
Verified
Journal Article
Open access
PDF file
HKHyeon-Kyoung Koo
Hyeon-Kyoung Koo
HKHyung Koo Kang
Hyung Koo Kang
PSPamela Song
Pamela Song
HPHye Kyeong Park
Hye Kyeong Park
SLSung-Soon Lee
Sung-Soon Lee
HJHoon Jung
Hoon Jung
Koo HK, et al. Tuberc Respir Dis. 2017 Jul;80(3):304-310. https://doi.org/10.4046/trd.2017.80.3.304

21 October 2016 in Respirology
Verified
Journal Article
Closed access
PDF file
BSBeomsu Shin
Beomsu Shin
KKKang Kim
Kang Kim
Byeong-Ho JeongByeong-Ho Jeong
Byeong-Ho Jeong
JEJung Seop Eom
Jung Seop Eom
WSWon Jun Song
Won Jun Song
HKHojoong Kim
Hojoong Kim

Verified
Journal Article
Open access
PDF file
BYBumhee Yang
Bumhee Yang
KHKyungdo Han
Kyungdo Han
BKBONGSEONG KIM
BONGSEONG KIM
HKHyung Koo Kang
Hyung Koo Kang
JKJung Soo Kim
Jung Soo Kim
Hyun LeeHyun Lee
Hyun Lee
Smoking traditionally has not been considered as a cause of bronchiectasis. However, few studies have evaluated the association between smoking and bronchiectasis. This study aimed to investigate the association between smoking status and bronchiectasis development in young adults. This study included 6,861,282 adults aged 20–39 years from the Korean National Health Insurance Service database 2009–2012 who were followed-up until the date of development of bronchiectasis, death, or 31 December 2018. We evaluated the incidence of bronchiectasis according to smoking status. During a mean of 7.4 years of follow-up, 23,609 (0.3%) participants developed bronchiectasis. In multivariable Cox regression analysis, ex-smokers (adjusted hazard ratio (aHR) = 1.07, 95% confidence interval (CI) = 1.03–1.13) and current-smokers (aHR = 1.06, 95% CI = 1.02–1.10) were associated with incident bronchiectasis, with the highest HR in ≥ 10 pack-years current smokers (aHR = 1.12, 95% CI = 1.06–1.16). The association of smoking with bronchiectasis was more profound in females than in males (p for interaction < 0.001), in younger than in older participants (p for interaction = 0.036), and in the overweight and obese than in the normal weight or underweight (p for interaction = 0.023). In conclusion, our study shows that smoking is associated with incident bronchiectasis in young adults. The association of smoking with bronchiectasis development was stronger in females, 20–29 year-olds, and the overweight and obese than in males, 30–40-year-olds, and the normal weight or underweight, respectively.

24 January 2017 in Respirology
Verified
Journal Article
Open access
PDF file
BSBeomsu Shin
Beomsu Shin
Hyun LeeHyun Lee
Hyun Lee
DKDanbee Kang
Danbee Kang
Byeong-Ho JeongByeong-Ho Jeong
Byeong-Ho Jeong
HKHyung Koo Kang
Hyung Koo Kang
HPHye Yun Park
Hye Yun Park
Background and objective: The association between airflow limitation severity and post‐operative pulmonary complications (PPCs) among COPD patients undergoing extra‐pulmonary surgery is unknown. We evaluated the association between forced expiratory volume in 1 s (FEV1 ) and PPC in COPD patients undergoing extra‐pulmonary surgery.Methods: Using prospective cohort of PPC evaluation for extra‐pulmonary surgery, we identified 694 COPD patients who conducted PPC evaluation before extra‐pulmonary surgery between March 2014 and January 2015 at a tertiary hospital, Seoul, Korea.Results: The overall incidence of PPC was 24.4%. The incidence of PPC in quintiles 1–5 of FEV1 (% predicted) was 31.4, 25.8, 23.7, 21.6 and 19.7%, respectively (P for trend: 0.019). In fully adjusted multivariable models, the relative risks (RRs, 95% CI) for PPC comparing participants in quintiles 1–4 of FEV1 (% predicted) with those in quintile 5 were 1.69 (1.03–2.79), 1.41 (0.83–2.37), 1.26 (0.75–2.11) and 1.30 (0.76–2.22), respectively (P for trend: 0.046). The association of severe airflow limitation with respiratory failure and post‐operative exacerbations was stronger in participants who did not use bronchodilators compared with those who did.Conclusion: We found a progressive and significant relationship between severity of airflow limitation and the incidence of PPC in COPD patients undergoing extra‐pulmonary surgery. Furthermore, perioperative bronchodilator use was associated with a reduced risk of respiratory failure and post‐operative exacerbations in patients with severe airflow limitation.